obesity
Conditions
Interventions
Intervention Group:Acupoints used in the intervention group: Baihui (GV20) ,Shenting (GV24) , Yintang (EX-HN3) , Shuifen (CV9) ,Tianshu (ST25), bilateral ,Shuidao (ST28), bilateral ,Sanyinjiao (SP6)
Control Group:Acupuncture will be applied at the following acupoints: Quchi (LI11), Tianshu (ST25), Daheng (SP15), Fenglong (ST40), and Yinlingquan (SP9), all bilaterally.
Sponsors
Affiliated Hospital of Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with simple obesity according to Western medicine diagnostic criteria. 2.Aged between 18 and 60 years, regardless of sex. 3.No other weight loss interventions undertaken within 2 months prior to participation in this study. 4.Able to communicate effectively, provide a complete description of their condition, sign the informed consent form, and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1.Patients with secondary obesity, such as that caused by hypothalamic syndrome, pituitary tumors, Cushing's syndrome, hypogonadism, or drug-induced obesity, as well as those diagnosed with metabolic syndrome. 2.Pregnant or lactating women. 3.Patients with severe primary diseases affecting the cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic systems, or those with psychiatric disorders. 4.Individuals unable to provide informed consent due to intellectual disability or behavioral disorders. 5.Patients with suspected or confirmed history of alcohol or drug abuse. 6.Other conditions deemed by the investigators to reduce the likelihood of enrollment or complicate participation, such as frequent changes in work environment that may increase the risk of loss to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body weight;Waist circumference;Body Mass Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in subcutaneous adipose tissue (SAT);Lipid profile;Changes in vagus nerve function;Changes in visceral adipose tissue (VAT); | — |
Countries
China
Contacts
Public ContactMengqian Yuan
Affiliated Hospital of Nanjing University of Chinese Medicine
Outcome results
None listed